Medicus Pharma Ltd. - Common shares, no par value (MDCX)

23 filings reported holding MDCX - Medicus Pharma Ltd. - Common shares, no par value as of Q2 2025.
Medicus Pharma Ltd. - Common shares, no par value (MDCX) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,206,052 shares of 18,751,984 outstanding shares and own 11.76% of the company stock.
Largest 10 shareholders include Interchange Capital Partners, LLC (1,586,871 shares), Private Advisor Group, LLC (146,000 shares), Yorkville Advisors Global, LP (105,840 shares), GUYASUTA INVESTMENT ADVISORS INC (76,911 shares), Verition Fund Management LLC (53,385 shares), SeaCrest Wealth Management, LLC (46,624 shares), CITADEL ADVISORS LLC (41,099 shares), May Hill Capital, LLC (35,622 shares), UBS Group AG (30,926 shares), and BlackRock, Inc. (15,764 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.